GLP-1 clinical trials in Maryland: 25 recruiting now

30 sites in 8 Maryland cities. Registry checked October 16, 2026.

Screening for a study can take weeks. Two cash programs to check.

No insurance needed.

  1. SnagRx$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
  2. Medvi$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up

Weight-loss studies (7)

Weight-loss study of cagrilintide

Where: Baltimore

What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.

Free to join

Who can join: Children and teens 8 to 18 who are overweight.

Study record on ClinicalTrials.gov

Barry J. Reiner, MD LLC, Baltimore

Weight-loss study of cagrisema

Where: Rockville

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.

Free to join

Who can join: Adults 18+ with obesity, BMI 35+.

Study record on ClinicalTrials.gov

Endo and Metabolic Consultants, Rockville

Show 4 more studies

Weight-loss study of tirzepatide

Where: Baltimore

What: Tests a GLP-1 and GIP medicine, tirzepatide, in people with chronic weight management.

Free to join

Who can join: Adults 18 to 65 with chronic weight management.

Study record on ClinicalTrials.gov

Ascletis Clinical Site, Baltimore

Weight-loss study of semaglutide

Where: Baltimore

What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people with type 2 diabetes lose weight.

Free to join

Who can join: Adults 18+ who are overweight.

Study record on ClinicalTrials.gov

PAREXEL Intl - EPCU-Baltimore, Baltimore

Weight-loss study of tirzepatide

Where: Baltimore

What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with type 2 diabetes lose weight.

Free to join

Who can join: Adults 18+ who are overweight.

Study record on ClinicalTrials.gov

PAREXEL Intl - EPCU-Baltimore, Baltimore

Type 2 diabetes studies (3)

Type 2 diabetes study of semaglutide

Where: Rockville

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Study record on ClinicalTrials.gov

Research Site, Rockville

Type 2 diabetes study of survodutide

Where: Rockville

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Endocrine and Metabolic Consultants, Rockville. 833-602-2368

Type 2 diabetes study of UBT251

Where: Oxon Hill

What: Tests whether an investigational medicine from Novo Nordisk, UBT251, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18 to 75 with type 2 diabetes.

Study record on ClinicalTrials.gov

MD Medical Research, Oxon Hill

Other GLP-1 studies in Maryland (15)

Fatty liver disease (MASLD) study of retatrutide

Where: Baltimore and Chevy Chase

What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.

Call the site: 410-332-9356Study record on ClinicalTrials.gov

Mercy Medical Center - Baltimore, Baltimore. 410-332-9356

Capital Digestive Care - Chevy Chase, Chevy Chase. 301-841-6869

Peripheral artery disease study of orforglipron

Where: Bowie and Lanham

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people improve blood flow in the legs.

Free to join

Who can join: Adults 18+ with peripheral artery disease (poor blood flow in the legs), BMI 23+.

Call the site: 410-824-1341Study record on ClinicalTrials.gov

Flourish Research - Bowie, Bowie. 410-824-1341

Capitol Cardiology Associates - Lanham Office, Lanham. 561-906-0904

Fatty liver disease with liver scarring study of survodutide

Where: Baltimore

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Mercy Medical Center, Baltimore. 833-602-2368

Show 12 more studies

Ulcerative colitis study of tirzepatide

Where: Chevy Chase

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.

Free to join

Who can join: Adults 18 to 70 with ulcerative colitis, BMI 27+.

Study record on ClinicalTrials.gov

Capital Digestive Care - Chevy Chase, Chevy Chase

Crohn's disease study of tirzepatide

Where: Chevy Chase

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.

Free to join

Who can join: Adults 18 to 70 with Crohn's disease, BMI 27+.

Study record on ClinicalTrials.gov

Capital Digestive Care - Chevy Chase, Chevy Chase

Psoriasis study of tirzepatide

Where: Rockville

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people calm psoriasis.

Free to join

Who can join: Adults 18+ with psoriasis, BMI 27+.

Study record on ClinicalTrials.gov

Dermatology and Skin Cancer Specialists, LLC, Rockville

Central centrifugal cicatricial alopecia (CCCA) study of tirzepatide

Where: Baltimore and Columbia

What: Tests a GLP-1 and GIP medicine, tirzepatide, in people with central centrifugal cicatricial alopecia (CCCA).

Free to join

Who can join: Adults 18 to 80 with central centrifugal cicatricial alopecia (CCCA).

Call the site: 443-597-6380Study record on ClinicalTrials.gov

Johns Hopkins Outpatient Center, Baltimore. 443-597-6380

Medical Pavilion at Howard County, Columbia. 443-597-6380

Fatty liver disease (also called MASH or NASH) study of semaglutide

Where: Bethesda

What: Tests whether a GLP-1 medicine, semaglutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.

Call the site: 800-411-1222Study record on ClinicalTrials.gov

National Institutes of Health Clinical Center, Bethesda. 800-411-1222

Opioid use disorder study of semaglutide

Where: Baltimore

What: Tests whether a GLP-1 medicine, semaglutide, can help people with opioid use disorder cut down on opioids.

Free to join

Who can join: Adults 18 to 75 with opioid use disorder, BMI 18+.

Study record on ClinicalTrials.gov

University of Maryland Baltimore, Baltimore

Metabolic alcohol-associated liver disease study of tirzepatide

Where: Bethesda

What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people reduce liver fat.

Free to join

Who can join: Adults 21+ with metabolic alcohol-associated liver disease, BMI 25+.

Call the site: 800-411-1222Study record on ClinicalTrials.gov

National Institutes of Health Clinical Center, Bethesda. 800-411-1222

Alcohol use disorder study of tirzepatide

Where: Bethesda

What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with alcohol use disorder drink less.

Free to join

Who can join: Adults 21 to 65 with alcohol use disorder, BMI 23+.

Call the site: 800-411-1222Study record on ClinicalTrials.gov

National Institutes of Health Clinical Center, Bethesda. 800-411-1222

Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.